Endoscopic injection of adrenaline for actively bleeding ulcers

a randomised trial

S. C. S. Chung, J. W. C. Leung, R. J. C. Steele, T. J. Crofts, A. K. Li

    Research output: Contribution to journalArticle

    185 Citations (Scopus)

    Abstract

    A prospective randomised trial was performed to assess the efficacy of endoscopic injection of adrenaline for actively bleeding ulcers. Emergency endoscopy in 961 patients admitted for upper gastrointestinal haemorrhage identified 68 patients with actively bleeding ulcers. These 68 patients were randomised to receive either endoscopic injection of adrenaline or no endoscopic treatment. After endoscopy both groups were managed in an identical manner, and strict criteria for emergency operation were adhered to in both groups. Bleeding was initially controlled in all 34 patients assigned to the treatment group. Significantly fewer patients in the treatment group than in the control group needed emergency operations (five v 14, respectively). In addition, in the treatment group the median transfusion requirement was significantly less (three v five units of blood) and the median hospital stay shorter (six v eight days). No complications were observed with the injection of adrenaline, and the rate of healing of ulcers in those attending for endoscopy six weeks after discharge was similar in both groups (81% (17 out of 21 patients) in the treatment group v 79% (11 out of 14) in the control group). Injection of adrenaline is effective in stopping bleeding from actively bleeding ulcers.
    Original languageEnglish
    Pages (from-to)1631-1633
    Number of pages3
    JournalBMJ (Clinical Research Ed.)
    Volume296
    Issue number6637
    DOIs
    Publication statusPublished - 1988

    Fingerprint

    Epinephrine
    Ulcer
    Hemorrhage
    Injections
    Endoscopy
    Emergencies
    Therapeutics
    Control Groups
    Gastrointestinal Hemorrhage
    Length of Stay

    Keywords

    • Clinical Trials as Topic
    • Duodenal Ulcer
    • Emergencies
    • Endoscopy
    • Epinephrine
    • Female
    • Humans
    • Injections
    • Male
    • Middle Aged
    • Peptic Ulcer Hemorrhage
    • Prospective Studies
    • Random Allocation
    • Stomach Ulcer

    Cite this

    Chung, S. C. S. ; Leung, J. W. C. ; Steele, R. J. C. ; Crofts, T. J. ; Li, A. K. / Endoscopic injection of adrenaline for actively bleeding ulcers : a randomised trial. In: BMJ (Clinical Research Ed.). 1988 ; Vol. 296, No. 6637. pp. 1631-1633.
    @article{96b645a2b6a242c18f2ecc021b9f58b2,
    title = "Endoscopic injection of adrenaline for actively bleeding ulcers: a randomised trial",
    abstract = "A prospective randomised trial was performed to assess the efficacy of endoscopic injection of adrenaline for actively bleeding ulcers. Emergency endoscopy in 961 patients admitted for upper gastrointestinal haemorrhage identified 68 patients with actively bleeding ulcers. These 68 patients were randomised to receive either endoscopic injection of adrenaline or no endoscopic treatment. After endoscopy both groups were managed in an identical manner, and strict criteria for emergency operation were adhered to in both groups. Bleeding was initially controlled in all 34 patients assigned to the treatment group. Significantly fewer patients in the treatment group than in the control group needed emergency operations (five v 14, respectively). In addition, in the treatment group the median transfusion requirement was significantly less (three v five units of blood) and the median hospital stay shorter (six v eight days). No complications were observed with the injection of adrenaline, and the rate of healing of ulcers in those attending for endoscopy six weeks after discharge was similar in both groups (81{\%} (17 out of 21 patients) in the treatment group v 79{\%} (11 out of 14) in the control group). Injection of adrenaline is effective in stopping bleeding from actively bleeding ulcers.",
    keywords = "Clinical Trials as Topic, Duodenal Ulcer, Emergencies, Endoscopy, Epinephrine, Female, Humans, Injections, Male, Middle Aged, Peptic Ulcer Hemorrhage, Prospective Studies, Random Allocation, Stomach Ulcer",
    author = "Chung, {S. C. S.} and Leung, {J. W. C.} and Steele, {R. J. C.} and Crofts, {T. J.} and Li, {A. K.}",
    year = "1988",
    doi = "10.1136/bmj.296.6637.1631",
    language = "English",
    volume = "296",
    pages = "1631--1633",
    journal = "BMJ (Clinical Research Ed.)",
    issn = "0267-0623",
    number = "6637",

    }

    Endoscopic injection of adrenaline for actively bleeding ulcers : a randomised trial. / Chung, S. C. S.; Leung, J. W. C.; Steele, R. J. C.; Crofts, T. J.; Li, A. K.

    In: BMJ (Clinical Research Ed.), Vol. 296, No. 6637, 1988, p. 1631-1633.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Endoscopic injection of adrenaline for actively bleeding ulcers

    T2 - a randomised trial

    AU - Chung, S. C. S.

    AU - Leung, J. W. C.

    AU - Steele, R. J. C.

    AU - Crofts, T. J.

    AU - Li, A. K.

    PY - 1988

    Y1 - 1988

    N2 - A prospective randomised trial was performed to assess the efficacy of endoscopic injection of adrenaline for actively bleeding ulcers. Emergency endoscopy in 961 patients admitted for upper gastrointestinal haemorrhage identified 68 patients with actively bleeding ulcers. These 68 patients were randomised to receive either endoscopic injection of adrenaline or no endoscopic treatment. After endoscopy both groups were managed in an identical manner, and strict criteria for emergency operation were adhered to in both groups. Bleeding was initially controlled in all 34 patients assigned to the treatment group. Significantly fewer patients in the treatment group than in the control group needed emergency operations (five v 14, respectively). In addition, in the treatment group the median transfusion requirement was significantly less (three v five units of blood) and the median hospital stay shorter (six v eight days). No complications were observed with the injection of adrenaline, and the rate of healing of ulcers in those attending for endoscopy six weeks after discharge was similar in both groups (81% (17 out of 21 patients) in the treatment group v 79% (11 out of 14) in the control group). Injection of adrenaline is effective in stopping bleeding from actively bleeding ulcers.

    AB - A prospective randomised trial was performed to assess the efficacy of endoscopic injection of adrenaline for actively bleeding ulcers. Emergency endoscopy in 961 patients admitted for upper gastrointestinal haemorrhage identified 68 patients with actively bleeding ulcers. These 68 patients were randomised to receive either endoscopic injection of adrenaline or no endoscopic treatment. After endoscopy both groups were managed in an identical manner, and strict criteria for emergency operation were adhered to in both groups. Bleeding was initially controlled in all 34 patients assigned to the treatment group. Significantly fewer patients in the treatment group than in the control group needed emergency operations (five v 14, respectively). In addition, in the treatment group the median transfusion requirement was significantly less (three v five units of blood) and the median hospital stay shorter (six v eight days). No complications were observed with the injection of adrenaline, and the rate of healing of ulcers in those attending for endoscopy six weeks after discharge was similar in both groups (81% (17 out of 21 patients) in the treatment group v 79% (11 out of 14) in the control group). Injection of adrenaline is effective in stopping bleeding from actively bleeding ulcers.

    KW - Clinical Trials as Topic

    KW - Duodenal Ulcer

    KW - Emergencies

    KW - Endoscopy

    KW - Epinephrine

    KW - Female

    KW - Humans

    KW - Injections

    KW - Male

    KW - Middle Aged

    KW - Peptic Ulcer Hemorrhage

    KW - Prospective Studies

    KW - Random Allocation

    KW - Stomach Ulcer

    U2 - 10.1136/bmj.296.6637.1631

    DO - 10.1136/bmj.296.6637.1631

    M3 - Article

    VL - 296

    SP - 1631

    EP - 1633

    JO - BMJ (Clinical Research Ed.)

    JF - BMJ (Clinical Research Ed.)

    SN - 0267-0623

    IS - 6637

    ER -